Altered gene expression in blood and sputum in COPD frequent exacerbators in the ECLIPSE cohort.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 4179270)

Published in PLoS One on September 29, 2014

Authors

Dave Singh1, Steven M Fox2, Ruth Tal-Singer3, Stewart Bates2, John H Riley4, Bartolome Celli5

Author Affiliations

1: University of Manchester, Medicines Evaluation Unit, Manchester, United Kingdom.
2: GlaxoSmithKline, Medicines Research Centre, Stevenage, United Kingdom.
3: GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.
4: GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom.
5: Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.

Associated clinical trials:

Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints (ECLIPSE) | NCT00292552

Articles cited by this

The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med (2004) 17.08

Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 15.07

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 10.05

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39

NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol (2005) 6.25

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J (2008) 4.53

Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med (2006) 4.11

COPD exacerbations: defining their cause and prevention. Lancet (2007) 3.46

BCL2 family in DNA damage and cell cycle control. Cell Death Differ (2006) 2.42

Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res (2006) 2.40

Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Curr Opin Immunol (2010) 1.68

Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J Immunol (1997) 1.34

TCR recognition of peptide/MHC class II complexes and superantigens. Semin Immunol (2007) 1.30

LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias. Blood (1996) 1.24

Apoptosis mediated by the TNF-related cytokine and receptor families. J Cell Biochem (1996) 1.19

Identification and characterization of a new phospholipase C-like protein, PLC-L(2). Biochem Biophys Res Commun (1999) 1.13

Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2013) 1.12

Lack of CD200 enhances pathological T cell responses during influenza infection. J Immunol (2009) 1.11

Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum (2003) 1.06

Peripheral blood gene expression profiles in COPD subjects. J Clin Bioinforma (2011) 0.99

B cell receptor signaling and autoimmunity. FASEB J (2001) 0.97

CD22 regulates adaptive and innate immune responses of B cells. J Innate Immun (2010) 0.96

Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers. Thorax (2011) 0.95

Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions. Mol Immunol (2009) 0.95

The cytokine midkine supports neutrophil trafficking during acute inflammation by promoting adhesion via β2 integrins (CD11/CD18). Blood (2014) 0.92

Association of beta-1,3-N-acetylglucosaminyltransferase 1 and beta-1,4-galactosyltransferase 1, trans-Golgi enzymes involved in coupled poly-N-acetyllactosamine synthesis. Glycobiology (2009) 0.90

Syk mediates BCR- and CD40-signaling integration during B cell activation. Immunobiology (2010) 0.86

Identification of a negative regulatory region for the exchange activity and characterization of T332I mutant of Rho guanine nucleotide exchange factor 10 (ARHGEF10). J Biol Chem (2011) 0.85

Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia. Oncogene (2000) 0.85

Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategies. J Cell Sci (2012) 0.85

Down regulation of T cell receptor expression in COPD pulmonary CD8 cells. PLoS One (2013) 0.84